C + Meningococcal Polysaccharide Antigen Group A + Meningococcal Polysaccharide Antigen Group C + Meningococcal Polysaccharide Antigen Group W-135 + Meningococcal Polysaccharide Antigen Group Y + Meningococcal Polysaccharide Group A + Meningococcal Polysaccharide Group C + Meningococcal Polysaccharide Group W135 + Meningococcal Polysaccharide Group Y + Vacuna Antimeningocóccica Conjugada De Polisacárido De Los Grupos A + W-135 E Y + Tetanus Toxoid

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Brands with this exact combination

BrandComposition & strengthManufacturer
NIMENRIXAU CA EU MX
  • liquid C + Vacuna Antimeningocóccica Conjugada De Polisacárido De Los Grupos A + W-135 E Y
  • liquid Meningococcal Polysaccharide Antigen Group A 0.005 mg + Meningococcal Polysaccharide Antigen Group C 0.005 mg + Meningococcal Polysaccharide Antigen Group W-135 0.005 mg + Meningococcal Polysaccharide Antigen Group Y 0.005 mg + Tetanus Toxoid 0.044 mg
  • unknown Meningococcal Polysaccharide Group A + Meningococcal Polysaccharide Group C + Meningococcal Polysaccharide Group W135 + Meningococcal Polysaccharide Group Y + Tetanus Toxoid
PFIZER CANADA ULC

Same combination in other markets

Cross-market comparison is not available for this grouped name.

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.